Special Internet Prices.
Fast & Guaranteed worldwide Delivery!
Secure & FAST Online ordering.
Our Drugstore Is The Most Trusted Online Drug Supplier.
>> CLICK HERE TO ENTER >>>
ommendation No. i, regarding the issuance of a monthly ioumal, was adopted, the
umber to be issued July, 191 1.
ommendation No. 2, on the title of the journal (Journal of the American Pharma-
al Association), was adopted.
commendation No. 3, on the scope of the Journal, evoked considerable discussion,
was resolved that the editorials be limited to synoptical references to the contents
I current Journal, and that on stated questions such expressions be confined to the
le of the Association, if made at all, or if by special contributors, with their names
iab appended. It was resolved also that the Journal publish a note in each issue
le Association Online Lexapro will not hold itself resporsible for the expression of opinion of its
bators, and that personalities must be entirely eliminated.
ru decided also that original articles, and the Proceedings of the Association
lal. Council and Branch), be published in the Journal, together with selections of
&i articles, including pharmaceutical abtracts, from other journals,
ommendation No. 4, that unly approved papers and advertisements be accepted
Uicativin in the Joarnal, was adopted.
motion it was agreed that the Journal be sent to members monthly, and that the
t on the Progress of Pharmacy be issued annually as a ioufu/ yo]\ime at the end of
iscal year and sent to members also; both publications without charge. In addi-
lose members who notify the General Secretary a/ M^ beginning of each year may
5 a lound volume of both the Journal and the Report at the end 0/ the year^
:he payment of a price to be fixed by the Committee on Publication. The price of
( suggested, but the exact amount was left to the discretion of the committee.
as suggested that the editor of the Journal should prepare abstracts of domestic
aceutical journals, while the Reporter on the Progress of Pharmacy should confine
lews to foreign pharmaceutical journals; and that the matter of the pharmaceu-
ibstracts of the Journal should be kept standing, after publication, so that it
be used also in connection with the forei^in abstracts published in the Report at
d of the fiscal year. In this way the whole field of pharmaceutical hterature could
iewed in the annual Report at a minimum cost.
as resolved the Report on the Progress of Pharmacy include the list of officers,
>cy matter, constitution and by-laws, general rules, roll of members, list of mem-
tc, of the previous proceedings; and it was decided Online Lexapro also that the list of payments
rofoership dues now published in the Proceedings be not published in the new
ras agreed that a standing Committee of nine members be elected annually by the
il to supervise the publications, to take the place of the former Committee on
MINUTES OF THE TWELFTH SESSION.
*' Bulletin " and Committee on Publication, this committee to be known as the Coi
on Publication. The Committee was directed to prepare proper rules and reg
governing editing, publication and the censoring of advertisements.
It was Online Lexapro suggested that the subscription price of the Journal to non-members 1
$2 a year and the Report the same; but this was left to the discretion of the Co;
On Online Lexapro motion it was decided that the monthly ** Bulletin," as now published,
tinued Online Lexapro until July, 191 Online Lexapro 1, and that the average number of reading pages shall nol
48 pages per month.
C. S. N. Hallberg was elected Online Lexapro editor-in-chief of the Journal, and Charles Cas|
and C. Lewis Diehl, associate editors.
C. Lewis Diehl, Reporter on the Progress of Pharmacy, was instructed to p
list of the assistant editors he desires for the Report, to report to the Council lat
It was decided that the editor and two associate editors with the Treasurer
ex-officio members of the Committee on Publication. The other members electc
F.J. Wulling, Chairman; G. M. Beringer, M. I. Wilbert, F. W. Meissner ai
Moved by C. Caspari, Jr. seconded by Mr. England, that the editor of the *' E
and the Reporter on the Progress of Pharmacy of the Proceedings each re